Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy-Reference-Cited by-同舟云学术

Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy

Published:2016-07-14 Issue:10 Volume:6 Page:
ISSN:2162-3279
Container-title:Brain and Behavior
language:en
Short-container-title:Brain Behav

Author:

Dyer Wayne B.¹²,Tan Joanne C. G.¹²,Day Timothy³⁴,Kiers Lynette⁴,Kiernan Matthew C.²⁵,Yiannikas Con⁶,Reddel Stephen²⁷,Ng Karl²⁸,Mondy Phillip¹,Dennington Peta M.¹,Dean Melinda M.⁹,Trist Halina M.¹⁰,Remedios Cristobal²,Hogarth P. Mark¹⁰,Vucic Steve²¹¹,Irving David O.¹¹²

Affiliation:

1. Australian Red Cross Blood Service Alexandria NSW Australia

2. Sydney Medical School University of Sydney Camperdown NSW Australia

3. Cabrini Medical Centre Cabrini Hospital Malvern Vic. Australia

4. Department of Neurophysiology Royal Melbourne Hospital Parkville Vic. Australia

5. Brain and Mind Centre University of Sydney Camperdown NSW Australia

6. Burwest Neurophysiology Burwood NSW Australia

7. Department of Neurology Concord Repatriation and General Hospital Concord NSW Australia

8. Department of Neurophysiology Royal North Shore Hospital St Leonards NSW Australia

9. Australian Red Cross Blood Service Kelvin Grove Qld Australia

10. Burnet Institute Prahran Vic. Australia

11. Department of Neurology Westmead Hospital Westmead NSW Australia